Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Valneva SE: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

12 Apr 2014 Reuters Investment Profile 12 $20.00

Intercell AG (ICLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Intercell AG (ICLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Intercell AG (Intercell) is a biotec...

17 Feb 2014 GlobalData 29 $250.00

Valneva SE (VLS) - Financial Analysis Review

Valneva SE (VLS) - Financial Analysis Review Summary Valneva SE (Valneva) is a biotechnology company. It principally fo...

22 Nov 2013 GlobalData 26 $125.00

Wright Investors Service Comprehensive Report for Valneva SE

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

21 Aug 2013 Wright Reports 39 $449.00

Vivalis SA (VLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vivalis SA (VLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Vivalis SA (Vivalis) is a biopharmaceut...

23 Jul 2013 GlobalData 47 $250.00

Vivalis SA (VLS) - Financial Analysis Review

Vivalis SA (VLS) - Financial Analysis Review Summary Vivalis SA (Vivalis) is a biopharmaceutical company. It provides c...

14 Jun 2013 GlobalData 26 $125.00

VLS.PA - Event Transcript of Valneva SE conference call, Mar. 05, 2013 / 8:00AM ET

Edited Event Transcript of VLS.PA conference call, Mar. 05, 2013 / 8:00AM ET Boston, May 28, 2013 (Thomson StreetEvents...

05 Mar 2013 Thomson Reuters StreetEvents 10 $75.00

VIVALIS - VALNEVA SAY NEVER AGAIN

French stem cell company Vivalis, is to merge with the Austrian vaccine company Intercell, to create a new company called Val...

15 Jan 2013 Edison Investment Research 2 $10.00

VLS.PA - Event Transcript of Valneva SE conference call, Dec. 17, 2012 / 8:00AM ET

Edited Event Transcript of VLS.PA conference call, Dec. 17, 2012 / 8:00AM ET Boston, May 28, 2013 (Thomson StreetEvents...

17 Dec 2012 Thomson Reuters StreetEvents 13 $75.00

Vivalis SA (VLS) - Financial Analysis Review

Vivalis SA (VLS) - Financial Analysis Review Summary Vivalis SA (Vivalis) is a biopharmaceutical company. It provides cell ba...

27 Nov 2012 GlobalData 29 $125.00